Your browser doesn't support javascript.
loading
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
Anywaine, Zacchaeus; Barry, Houreratou; Anzala, Omu; Mutua, Gaudensia; Sirima, Sodiomon B; Eholie, Serge; Kibuuka, Hannah; Bétard, Christine; Richert, Laura; Lacabaratz, Christine; McElrath, M Juliana; De Rosa, Stephen C; Cohen, Kristen W; Shukarev, Georgi; Katwere, Michael; Robinson, Cynthia; Gaddah, Auguste; Heerwegh, Dirk; Bockstal, Viki; Luhn, Kerstin; Leyssen, Maarten; Thiébaut, Rodolphe; Douoguih, Macaya.
Afiliação
  • Anywaine Z; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Barry H; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
  • Anzala O; KAVI - Institute of Clinical Research University of Nairobi, Nairobi, Kenya.
  • Mutua G; KAVI - Institute of Clinical Research University of Nairobi, Nairobi, Kenya.
  • Sirima SB; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Unité de Recherche Clinique de Banfora, Banfora, Burkina Faso.
  • Eholie S; Unit of Infectious and Tropical Diseases, BPV3, Treichville University Teaching Hospital, Abidjan, Côte d'Ivoire.
  • Kibuuka H; Makerere University - Walter Reed Project, Kampala, Uganda.
  • Bétard C; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inria SISTM team; CHU Bordeaux; CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France.
  • Richert L; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219; Inria SISTM team; CHU Bordeaux; CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France.
  • Lacabaratz C; Vaccine Research Institute (VRI), Créteil, France.
  • McElrath MJ; Vaccine Research Institute (VRI), Créteil, France.
  • De Rosa SC; Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, Team 16, Créteil, France.
  • Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Shukarev G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Katwere M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Robinson C; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Gaddah A; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Heerwegh D; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Bockstal V; Janssen Research & Development, Beerse, Belgium.
  • Luhn K; Janssen Research & Development, Beerse, Belgium.
  • Leyssen M; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Thiébaut R; Janssen Vaccines and Prevention, Leiden, the Netherlands.
  • Douoguih M; Janssen Vaccines and Prevention, Leiden, the Netherlands.
PLoS Med ; 19(1): e1003865, 2022 01.
Article em En | MEDLINE | ID: mdl-35015777

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Imunidade Humoral / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Uganda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Imunidade Humoral / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Uganda